To ask the Scottish Government whether it will provide an update on what progress is being made to ensure that independent prescriber community pharmacists have appropriate read and write access to GP patient records in order to support safe and effective prescribing, and whether it will provide a timeline for when full access is expected to be in place.
The Scottish Government is committed to collaborate with key partners across the NHS in Scotland to ensure that relevant information, with the appropriate safeguards in place, is available to all healthcare professionals, including community pharmacists, when and where they need it.
As community pharmacists expand their clinical role, there is an increasing need for them to have read/write access to clinical records to ensure that they can safely assess and agree a clinical management plan for a person and any associated actions or treatments can be viewed by other healthcare professionals involved in a person’s care, without any unnecessary delay.
Community pharmacists currently have access to the Emergency Care Summary (ECS) which provides information on recent acute and repeat prescriptions and allergies and the Key Information Summary (KIS) where available, which provides information about a person’s health issues, a carer’s name and contact details, preferences on how a person would like to be cared for, the treatment they would like and where they would like to be cared for.
In addition, several health boards are providing community pharmacists access to their clinical portal which provides additional clinical information, although the level of access varies from Health Board to Health Board. Clinical portals support Health Boards to allow healthcare professionals to access information about an individual, including in some cases those from other Health Boards when required, with their permission.
There are several barriers that currently make full access to clinical records difficult including the interoperability of the different IT systems used across the NHS and providing assurances on data protection and information governance requirements.
The Chief Pharmaceutical Officer is exploring how read/write access to clinical records can be delivered incrementally.